drugset / Trial / NCT01315314
Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction
Phase 4
Completed
146 enrolled
Kyungpook National University Hospital
Fresenius Medical Care Korea · collabMinistry of Health & Welfare, Korea · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of neutral pH and low glucose degradation product (GDP)-containing peritoneal dialysis fluid (PDF) on systemic inflammation and endothelial dysfunction markers in incident PD patients.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ISOXAFLUTOLE | Other / unclassified | — | — |